CN Patent

CN111362967B — 苯并氧杂二氮杂十四碳烯衍生物及其用途

Assigned to Nanjing Leizheng Pharmaceutical Technology Co ltd · Expires 2021-09-07 · 5y expired

What this patent protects

本发明公开了苯并氧杂二氮杂十四碳烯衍生物及其用途，属于医药领域。本发明提供的具有通式(I)所示结构的一类苯并氧杂二氮杂十四碳烯衍生物具有优异的间变性淋巴瘤酶(ALK)抑制活性和优异的药效学性能，能够显著延长药物大代谢半衰期；可安全、有效的用于治疗间变性淋巴瘤激酶阳性(ALK+)转移性(晚期)非小细胞肺癌(NSCLC)等，从而为治疗癌症、代谢与免疫疾病、心血管病以及神经性疾病等提供新的手段。

USPTO Abstract

本发明公开了苯并氧杂二氮杂十四碳烯衍生物及其用途，属于医药领域。本发明提供的具有通式(I)所示结构的一类苯并氧杂二氮杂十四碳烯衍生物具有优异的间变性淋巴瘤酶(ALK)抑制活性和优异的药效学性能，能够显著延长药物大代谢半衰期；可安全、有效的用于治疗间变性淋巴瘤激酶阳性(ALK+)转移性(晚期)非小细胞肺癌(NSCLC)等，从而为治疗癌症、代谢与免疫疾病、心血管病以及神经性疾病等提供新的手段。

Drugs covered by this patent

Patent Metadata

Patent number
CN111362967B
Jurisdiction
CN
Classification
—
Expires
2021-09-07
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Leizheng Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.